Cleared Traditional

K821477 - WM. HARVEY H-1300 INFANT/PEDIATRIC BLOOD

K821477 is an FDA 510(k) clearance for WM. HARVEY H-1300 INFANT/PEDIATRIC BLOOD, manufactured by C.R. Bard, Inc.. The device is a Class 2 Cardiovascular device with product code DTZ cleared through the Traditional 510(k) pathway after a 167-day FDA review.

K821477 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1982
Decision
167d
Days
Class 2
Risk

K821477 is an FDA 510(k) clearance for the WM. HARVEY H-1300 INFANT/PEDIATRIC BLOOD. Classified as Oxygenator, Cardiopulmonary Bypass (product code DTZ), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Mchenry, US). The FDA issued a Cleared decision on November 1, 1982 after a review of 167 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4350 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all C.R. Bard, Inc. devices

FDA 510(k) Submission Details - K821477

510(k) Number K821477 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 1982
Decision Date November 01, 1982
Days to Decision 167 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 125d · This submission: 167d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DTZ Device Classification - Class 2, Special Controls

Product Code DTZ Oxygenator, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTZ Oxygenator, Cardiopulmonary Bypass

All 235
Devices cleared under the same product code (DTZ) and FDA review panel - the closest regulatory comparables to K821477.
OXYGENATORS #BOS-10, 105, 5S
K823456 · Bentley Laboratories, Inc. · Dec 1982
OXYGENATOR 10
K823343 · Gambro, Inc. · Dec 1982
CAPIOX II
K823125 · Terumo Medical Corp. · Nov 1982
BLOOD OXYGENATORS #BOS-105S BOS-5S W/
K822803 · Bentley Laboratories, Inc. · Nov 1982
INTERPULSE MEMBRANE OXYGENATOR
K821216 · Extracorporeal Medical Specialities, Inc. · Jun 1982
LPM/50 MEMBRANE OXYGENATOR
K813255 · Travenol Laboratories, S.A. · Jan 1982